Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Green Plants Extracts (GPE) is a French biotechnology company specializing in the development and production of high-quality botanical extracts for the cosmetic, nutraceutical, and pharmaceutical industries. Founded in 2002 and headquartered in Saint-Genis-Laval, the company utilizes advanced extraction and purification technologies to provide active ingredients derived from natural sources. GPE was acquired by Naturex in 2012, which was subsequently integrated into Givaudan following its 2018 acquisition of the Naturex group. The company is recognized for its expertise in custom extraction and its ability to isolate specific bioactive molecules for use in health and beauty products. GPE's offerings support a wide range of applications, including anti-aging, skin protection, and metabolic wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Plants Extracts.